Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies.

作者: Alaa A.-M. Abdel-Aziz , Adel S. El-Azab , Amer M. Alanazi , Yousif A. Asiri , Ibrahim A. Al-Suwaidan

DOI: 10.3109/14756366.2015.1069288

关键词:

摘要: The potential antitumor activities of a series 7-(4-substituted piperazin-1-yl)fluoroquinolone derivatives (1-14a,b) using ciprofloxacin and norfloxacin as scaffolds are described. These compounds exhibit potent broad spectrum 60 human cell lines in addition to the inherent antibacterial activity. Compounds 1a, 2a, 3b, 6b 7a were found be most potent, while 2b, 5b, 6a have an average results this study demonstrated that (mean GI50; 2.63-3.09 µM) nearly 7-fold more compared with positive control 5-fluorouracil 22.60 µM). More interestingly, almost activity similar gefitinib 3.24 µM) 2-fold erlotinib 7.29 µM). In silico ADME-Tox prediction methodology used active identify structural features required for

参考文章(44)
Bruce A. Chabner, Saul A. Schepartz, Michael R. Grever, The National Cancer Institute: cancer drug discovery and development program. Seminars in Oncology. ,vol. 19, pp. 622- 638 ,(1992) , 10.5555/URI:PII:009377549290032V
Heather Wakelee, Kristen N Ganjoo, Review of erlotinib in the treatment of advanced non-small cell lung cancer Biologics: Targets & Therapy. ,vol. 1, pp. 335- 346 ,(2007)
J. Carlos Menéndez, Carmen Avendaño, Medicinal chemistry of anticancer drugs Elsevier. ,(2008)
John S. Wolfson, David C. Hooper, Quinolone antimicrobial agents american Society for Microbiology. ,(1993)
Rachael E. Hawtin, David E. Stockett, Jo Ann W. Byl, Robert S. McDowell, Nguyen Tan, Michelle R. Arkin, Andrew Conroy, Wenjin Yang, Neil Osheroff, Judith A. Fox, Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II PLoS ONE. ,vol. 5, pp. e10186- ,(2010) , 10.1371/JOURNAL.PONE.0010186
M. Paul, A. Gafter-Gvili, A. Fraser, L. Leibovici, The anti-cancer effects of quinolone antibiotics? European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 26, pp. 825- 831 ,(2007) , 10.1007/S10096-007-0375-4
David E Clark, Stephen D Pickett, Computational methods for the prediction of 'drug-likeness' Drug Discovery Today. ,vol. 5, pp. 49- 58 ,(2000) , 10.1016/S1359-6446(99)01451-8
Yeh-Long Chen, Kuo-Chang Fang, Jia-Yuh Sheu, Shu-Lin Hsu, Cherng-Chyi Tzeng, Synthesis and Antibacterial Evaluation of Certain Quinolone Derivatives Journal of Medicinal Chemistry. ,vol. 44, pp. 2374- 2377 ,(2001) , 10.1021/JM0100335
M. Mirzaei, A. Foroumadi, Synthesis and In‐vitro Antibacterial Activity of N‐Piperazinyl Quinolone Derivatives with a 2‐Thienyl Group Pharmacy and Pharmacology Communications. ,vol. 6, pp. 351- 354 ,(2000) , 10.1211/146080800128736196